Jacob Emil Petersen

Jacob Emil Petersen is a Postdoctoral Researcher in the Schwartz Group at the Center for Basic Metabolic Research (CBMR), Faculty of Health and Medical Sciences, University of Copenhagen. His work focuses on G protein-coupled receptors (GPCRs) and their role in metabolic regulation and disease pathogenesis.

Dr. Petersen's research spans multiple disciplines within molecular pharmacology and metabolism. His primary focus is on tachykinin receptors (NK1 and NK2), free fatty acid receptors (FFAR1/FFAR4), and other GPCRs involved in energy homeostasis. He employs a multidisciplinary approach combining structural biology, molecular pharmacology, and in vivo studies to investigate receptor activation mechanisms, signaling bias, and develop novel therapeutic strategies for obesity and metabolic disorders. His work has contributed to understanding how neuropeptides interact with their receptors and how these interactions can be leveraged for therapeutic benefit.

Analysis of Dr. Petersen's publications reveals a consistent trajectory toward understanding receptor signaling mechanisms with direct therapeutic applications. His research increasingly integrates neuroscience, endocrinology, and pharmacology to address complex metabolic disorders. The publications show strong collaboration with interdisciplinary teams and have appeared in high-impact journals including Nature and Journal of Biological Chemistry, with several papers receiving significant media attention and citations.

As a member of the Schwartz Group at CBMR, Dr. Petersen contributes to one of Europe's leading research environments for metabolic disease research. The group focuses on understanding the molecular mechanisms underlying metabolic disorders and developing innovative therapeutic approaches. His work has practical implications for the development of new pharmacotherapies targeting GPCRs for obesity, diabetes, and related metabolic conditions, with several publications highlighting potential novel treatment strategies.